ICUI - ICU Medical, Inc.
ICU Medical, Inc. , together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs.
As of May 15, 2026: spot at $119.44, ATM IV 38.3%, net GEX -$20.9K.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Market Cap
- $3.05B
- P/E Ratio
- 65.22
- Beta
- 0.74
- 52-Week Range
- 107-160.29
- CEO
- Vivek Jain
- Employees
- 15,000
- IPO Date
- Mar 31, 1992
- Exchange
- NASDAQ
What ICUI Looks Like to Options Traders Today
IV rank of 10.6% is subdued relative to the 1-year history, conditions that typically favor premium-buying or long-volatility structures (debit spreads, calendar spreads, long straddles); negative net gamma exposure (-$20.9K) means dealers hedge with trend, amplifying realized volatility and accelerating directional moves; the 25-delta skew (0.033) prices calls richer than puts, often reflecting upside speculation or squeeze risk.
What This Page Covers
The ICUI overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked ICUI overview questions
- What is ICUI?
- ICUI is the ticker symbol for ICU Medical, Inc., a listed security. ICU Medical, Inc. , together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. Listed on NASDAQ. ICUI is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the ICUI options snapshot look like today?
- As of May 15, 2026, the ICUI options snapshot shows spot at $119.44, ATM IV 38.3%, IV rank 10.6%, net GEX -$20.9K, expected move 10.98%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are ICUI's key statistics?
- ICU Medical, Inc. (ICUI) carries a market capitalization of $3.05B, trailing P/E ratio of 65.22, beta of 0.74 relative to the broader market, 52-week range of 107-160.29. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does ICUI belong to?
- ICU Medical, Inc. operates in the Healthcare sector, in the Medical - Instruments & Supplies industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare ICUI's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the ICUI data on this page?
- The options snapshot above is dated May 15, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).